New Targeted Treatments for Fragile X Syndrome
Fragile X Syndrome (FXS) is the most common cause of inherited intellectual disability with prevalence rates estimated to be 1:5,000 in males and 1:8,000 in females. The increase of >200 Cytosine Guanine Guanine (CGG) repeats in the 5' untranslated region of the Fragile X Mental Retardation...
Saved in:
Main Authors: | Protic, Dragana, Salcedo-Arellano, Maria J, Dy, Jeanne Barbara, Potter, Laura A, Hagerman, Randi J |
---|---|
Format: | text |
Published: |
Archīum Ateneo
2019
|
Subjects: | |
Online Access: | https://archium.ateneo.edu/asmph-pubs/37 https://archium.ateneo.edu/cgi/viewcontent.cgi?article=1034&context=asmph-pubs |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Ateneo De Manila University |
Similar Items
-
Fragile X- associated Neuropsychiatric Disorders: A Case Report
by: Tan, Maria Melinda, et al.
Published: (2019) -
Metformin as Targeted Treatment in Fragile X Syndrome
by: Dy, Angel Belle C, et al.
Published: (2017) -
Molecular screening for fragile x syndrome in Thailand
by: Pornprot Limprasert, et al.
Published: (1999) -
Autism Symptoms in Fragile X Syndrome
by: Niu, Manman, et al.
Published: (2017) -
Multiplex methylation specific PCR Analysis of fragile X syndrome
by: Chariyawan Charalsawadi
Published: (2005)